Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early levosimendan for acute decompensation of chronic heart failure in the emergency department
2007-002447-25Phase 4Active
- Sponsor
- Hospital General Universitario de Alicante
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of levosimendan in heart failure (HF) and chronic heart failure (CHF) (2 arms), sponsored by Hospital General Universitario de Alicante. Primary endpoints: Improvement in dyspnea and Serial dyspnea assessments over 48 hours. Started Oct 2007; status: active.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2007-002447-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002447-25.